Unleash Your Potential: Johnson & Johnson's 'Dual Control' Empowers IBD Patients in Asia Pacific

Unmasking the Gut's Hidden Sentinel: A DNA Pathway's Role in Inflammation

Tiziana Life Sciences Soars: Beyond Foralumab, a Second Asset Ignites Investor Excitement and Future Potential

An 8-Year-Old's Heartwarming Mission: Customizing NG Tube Covers to Bring Joy to Kids Nationwide

Beyond the Visible: The Unseen Struggles of Invisible Disabilities in Accessible Parking

Groundbreaking Study Dispels Fears: Antibiotics Unlikely to Trigger Most Autoimmune Diseases

Navigating the Labyrinth of Inflammatory Bowel Disease: A Deep Dive

The Autoimmune Revolution: IL-23 Inhibitors Poised for Massive Market Growth